Page last updated: 2024-11-07

penicillamine and Granulocytic Leukemia, Chronic

penicillamine has been researched along with Granulocytic Leukemia, Chronic in 2 studies

Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaşifoğlu, T1
Korkmaz, C1
Yaşar, S1
Gülbaş, Z1
Ferry-Dumazet, H1
Mamani-Matsuda, M1
Dupouy, M1
Belloc, F1
Thiolat, D1
Marit, G1
Arock, M1
Reiffers, J1
Mossalayi, MD1

Other Studies

2 other studies available for penicillamine and Granulocytic Leukemia, Chronic

ArticleYear
Scleroderma and chronic myeloid leukemia: a sheer coincidence, a consequence of long lasting D-penicillamine therapy or a plausible relationship of both diseases?
    Rheumatology international, 2006, Volume: 27, Issue:2

    Topics: Antirheumatic Agents; CREST Syndrome; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positi

2006
Nitric oxide induces the apoptosis of human BCR-ABL-positive myeloid leukemia cells: evidence for the chelation of intracellular iron.
    Leukemia, 2002, Volume: 16, Issue:4

    Topics: Apoptosis; Cell Cycle; Cell Division; Cells, Cultured; Ferricyanides; Fusion Proteins, bcr-abl; Huma

2002